Advantage Alpha Capital Partners LP Reduces Holdings in Encompass Health Co. (NYSE:EHC)

Advantage Alpha Capital Partners LP reduced its stake in shares of Encompass Health Co. (NYSE:EHC) by 16.0% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 75,435 shares of the company’s stock after selling 14,350 shares during the period. Encompass Health comprises approximately 1.7% of Advantage Alpha Capital Partners LP’s portfolio, making the stock its 8th biggest position. Advantage Alpha Capital Partners LP’s holdings in Encompass Health were worth $7,290,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of EHC. Harbor Capital Advisors Inc. lifted its position in shares of Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock valued at $3,071,000 after purchasing an additional 26,270 shares in the last quarter. QRG Capital Management Inc. lifted its position in shares of Encompass Health by 85.6% during the 2nd quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock worth $1,232,000 after buying an additional 6,627 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Encompass Health in the 2nd quarter worth approximately $2,204,000. Los Angeles Capital Management LLC grew its holdings in shares of Encompass Health by 532.4% in the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after acquiring an additional 42,338 shares in the last quarter. Finally, Kennedy Capital Management LLC increased its position in shares of Encompass Health by 19.6% during the first quarter. Kennedy Capital Management LLC now owns 99,720 shares of the company’s stock valued at $8,235,000 after acquiring an additional 16,318 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Performance

NYSE EHC opened at $102.00 on Tuesday. The company’s 50 day simple moving average is $97.28 and its two-hundred day simple moving average is $90.99. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The stock has a market capitalization of $10.28 billion, a PE ratio of 24.64, a P/E/G ratio of 1.34 and a beta of 0.88.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter last year, the business posted $0.86 earnings per share. The firm’s revenue was up 11.9% compared to the same quarter last year. Analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is 16.43%.

Analyst Ratings Changes

EHC has been the topic of several research analyst reports. UBS Group boosted their price objective on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Royal Bank of Canada increased their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Stephens reiterated an “overweight” rating and issued a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. Truist Financial restated a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, Barclays upped their price target on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.